Literature DB >> 8327105

Olivary degeneration after cerebellar or brain stem haemorrhage: MRI.

A Uchino1, K Hasuo, K Uchida, S Matsumoto, Y Tsukamoto, M Ohno, K Masuda.   

Abstract

Magnetic resonance (MR) images of seven patients with olivary degeneration caused by cerebellar or brain stem haemorrhages were reviewed. In four patients with cerebellar haemorrhage, old haematomas were identified as being located in the dentate nucleus; the contralateral inferior olivary nuclei were hyperintense on proton-density- and T2-weighted images. In two patients with pontine haemorrhages, the old haematomas were in the tegmentum and the ipsilateral inferior olivary nuclei, which were hyperintense. In one case of midbrain haemorrhage, the inferior olivary nuclei were hyperintense bilaterally. The briefest interval from the ictus to MRI was 2 months. Hypertrophic olivary nuclei were observed only at least 4 months after the ictus. Olivary degeneration after cerebellar or brain stem haemorrhage should not be confused with ischaemic, neoplastic, or other primary pathological conditions of the medulla.

Entities:  

Mesh:

Year:  1993        PMID: 8327105     DOI: 10.1007/bf00588362

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  MR demonstration of a unilateral olivary hypertrophy caused by pontine tegmental hematoma.

Authors:  N Hirono; M Kameyama; Y Kobayashi; F Udaka; T Mezaki; K Abe; N Nishitani
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  MR imaging of presumed olivary hypertrophy in palatal myoclonus.

Authors:  J J Zarranz; A Fontan; I Forcadas
Journal:  AJNR Am J Neuroradiol       Date:  1990 Nov-Dec       Impact factor: 3.825

3.  MR appearance of hypertrophic olivary degeneration after contralateral cerebellar hemorrhage.

Authors:  M P Revel; M Mann; P Brugieres; J Poirier; A Gaston
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jan-Feb       Impact factor: 3.825

4.  Palatal myoclonus and inferior olivary lesions: MRI-pathologic correlation.

Authors:  L Pierot; P Cervera-Pierot; J Y Delattre; C Duyckaerts; J Chiras; P Brunet
Journal:  J Comput Assist Tomogr       Date:  1992 Jan-Feb       Impact factor: 1.826

5.  Cerebellorubral degeneration after resection of cerebellar dentate nucleus neoplasms: evaluation with MR imaging.

Authors:  N P Bontozoglou; D W Chakeres; G F Martin; M A Brogan; R B McGhee
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

6.  Hypertrophy of the inferior olives. Report on 29 cases.

Authors:  K Jellinger
Journal:  Z Neurol       Date:  1973

7.  Olivary enlargement: chronological and morphometric analyses.

Authors:  N Goto; M Kaneko
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

8.  Increased glucose metabolism in the medulla of patients with palatal myoclonus.

Authors:  R M Dubinsky; M Hallett; G Di Chiro; M Fulham; J Schwankhaus
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

9.  MRI findings of inferior olives in palatal myoclonus.

Authors:  T Yokota; F Hirashima; T Furukawa; H Tsukagoshi; H Yoshikawa
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

10.  Syndrome of palatal myoclonus and progressive ataxia: two cases with magnetic resonance imaging.

Authors:  M R Sperling; C Herrmann
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

View more
  14 in total

1.  Hypertrophic olivary degeneration with gadolinium enhancement after posterior fossa surgery in a child with medulloblastoma.

Authors:  Johannes Nowak; Balint Alkonyi; Stefan Rutkowski; György A Homola; Monika Warmuth-Metz
Journal:  Childs Nerv Syst       Date:  2014-05       Impact factor: 1.475

2.  Vertical pendular nystagmus and hypertrophic inferior olivary nuclei degeneration: an "odd couple".

Authors:  Antonio Carota; Norbert Düron; Carlo Cereda; Claudio L Bassetti
Journal:  J Neurol       Date:  2011-07-16       Impact factor: 4.849

3.  In vitro delineation of human brain-stem anatomy using a small resonator: correlation with macroscopic and histological findings.

Authors:  J Mäurer; T Mitrovic; F D Knollmann; E Lüdtke; H Requardt
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

4.  Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings.

Authors:  M Goyal; E Versnick; P Tuite; J S Cyr; W Kucharczyk; W Montanera; R Willinsky; D Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

5.  Serial MRI of olivary hypertrophy: long-term follow-up of a patient with the "top of the basilar" syndrome.

Authors:  S Terao; G Sobue; N Shimada; M Takahashi; Y Tsuboi; T Mitsuma
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

6.  Ipsilateral mamillary body atrophy after infarction of the posterior cerebral artery territory: MR imaging.

Authors:  Akira Uchino; Akihiro Sawada; Yukinori Takase; Keita Nomiyama; Ryoko Egashira; Sho Kudo
Journal:  Eur Radiol       Date:  2005-04-26       Impact factor: 5.315

7.  Brainstem and cerebellar changes after cerebrovascular accidents: magnetic resonance imaging.

Authors:  A Uchino; Y Takase; K Nomiyama; R Egashira; S Kudo
Journal:  Eur Radiol       Date:  2005-10-12       Impact factor: 5.315

8.  An MRI analysis of brain-stem and cerebellar lesions and olivary hypertrophy.

Authors:  Y Kawata; T Suzuki; H Kagaya; R Omi; H Shiroto; K Ebina
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

9.  Hypertrophic olivary degeneration after resection of a cerebellar tumor.

Authors:  Serra Akar; Jan Drappatz; Liangge Hsu; Russell A Blinder; Peter McL Black; Santosh Kesari
Journal:  J Neurooncol       Date:  2008-01-23       Impact factor: 4.130

10.  MR imaging evaluation of inferior olivary nuclei: comparison of postoperative subjects with and without posterior fossa syndrome.

Authors:  Z Patay; J Enterkin; J H Harreld; Y Yuan; U Löbel; Z Rumboldt; R Khan; F Boop
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.